M312 a case for oral challenge in patients with high peanut sensitivity to guide treatment decisions
Peanut allergy prevalence is increasing in the United States; it is a persistent allergy and common etiology of fatal and near-fatal anaphylaxis. Oral immunotherapy (OIT) is increasingly available to desensitize peanut-allergic children but optimal patient selection remains unknown.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: K. Tison, K. Patel, B. Vickery Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Children | Immunotherapy | Peanuts | USA Health